8-140668316-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001352702.2(PTK2):āc.2950A>Gā(p.Ser984Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000394 in 1,614,182 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00066 ( 1 hom., cov: 31)
Exomes š: 0.00037 ( 0 hom. )
Consequence
PTK2
NM_001352702.2 missense
NM_001352702.2 missense
Scores
1
5
13
Clinical Significance
Conservation
PhyloP100: 4.85
Genes affected
PTK2 (HGNC:9611): (protein tyrosine kinase 2) This gene encodes a cytoplasmic protein tyrosine kinase which is found concentrated in the focal adhesions that form between cells growing in the presence of extracellular matrix constituents. The encoded protein is a member of the FAK subfamily of protein tyrosine kinases but lacks significant sequence similarity to kinases from other subfamilies. Activation of this gene may be an important early step in cell growth and intracellular signal transduction pathways triggered in response to certain neural peptides or to cell interactions with the extracellular matrix. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.041706145).
BS2
High AC in GnomAd4 at 101 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTK2 | NM_001352702.2 | c.2950A>G | p.Ser984Gly | missense_variant | 34/36 | ENST00000696786.1 | NP_001339631.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTK2 | ENST00000696786.1 | c.2950A>G | p.Ser984Gly | missense_variant | 34/36 | NM_001352702.2 | ENSP00000512868.1 |
Frequencies
GnomAD3 genomes AF: 0.000664 AC: 101AN: 152178Hom.: 1 Cov.: 31
GnomAD3 genomes
AF:
AC:
101
AN:
152178
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000354 AC: 89AN: 251436Hom.: 0 AF XY: 0.000434 AC XY: 59AN XY: 135898
GnomAD3 exomes
AF:
AC:
89
AN:
251436
Hom.:
AF XY:
AC XY:
59
AN XY:
135898
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000366 AC: 535AN: 1461886Hom.: 0 Cov.: 31 AF XY: 0.000388 AC XY: 282AN XY: 727248
GnomAD4 exome
AF:
AC:
535
AN:
1461886
Hom.:
Cov.:
31
AF XY:
AC XY:
282
AN XY:
727248
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000663 AC: 101AN: 152296Hom.: 1 Cov.: 31 AF XY: 0.000779 AC XY: 58AN XY: 74476
GnomAD4 genome
AF:
AC:
101
AN:
152296
Hom.:
Cov.:
31
AF XY:
AC XY:
58
AN XY:
74476
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
4
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
29
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 10, 2021 | The c.2884A>G (p.S962G) alteration is located in exon 30 (coding exon 29) of the PTK2 gene. This alteration results from a A to G substitution at nucleotide position 2884, causing the serine (S) at amino acid position 962 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;T;T;T;.;.;.;T;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
.;D;D;.;D;D;D;D;D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;.;.;L;.;.;.;.;.;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.;N;N;N;N;N;N;N;N;N
REVEL
Benign
Sift
Benign
D;.;T;T;D;T;T;D;T;T;D
Sift4G
Benign
T;T;T;T;T;T;T;T;T;T;T
Polyphen
P;.;P;.;P;.;.;.;.;.;.
Vest4
MVP
MPC
0.70
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at